BeOne Medicines (ONC) Non-Current Debt (2015 - 2026)
BeOne Medicines' (ONC) quarterly Non-Current Debt came in at $882.2 million in Q2 2026, up 503.84% year-over-year from $146.1 million in Q2 2025, and down 8.35% quarter-over-quarter from $962.5 million in Q1 2026.
Powered by 
Analysis
BeOne Medicines (ONC) Non-Current Debt (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Non-Current Debt for 12 consecutive years, with $882.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Debt rose 503.84% year-over-year to $882.2 million in Q2 2026; TTM through Jun 2026 was $882.2 million, a 503.84% increase from a year earlier, with the FY2025 full-year figure at $961.9 million, up 477.78% from the prior year.
- Non-Current Debt was $882.2 million for Q2 2026 at BeOne Medicines, down from $962.5 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $962.5 million in Q1 2026 and troughed at $146.1 million in Q2 2025.
- A 5-year average of $350.1 million and a median of $202.0 million in 2022 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt retreated 21.15% in 2025 and jumped 503.84% in 2026, its largest moves.
- Over 5 years, Non-Current Debt stood at $209.1 million in 2022, then retreated by 5.51% to $197.6 million in 2023, then fell by 15.75% to $166.5 million in 2024, then jumped by 477.78% to $961.9 million in 2025, then dropped by 8.29% to $882.2 million in 2026.
- The last three Non-Current Debt figures came in at $882.2 million (Q2 2026), $962.5 million (Q1 2026), and $961.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | -5.81 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 57.30 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 26.25 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | - |
| 10 | BeOne Medicines | 41.25 Bn | 36.15 Bn | 1.53 Bn | 882.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 882.16 Mn |
| Mar 31, 2026 | 962.52 Mn |
| Dec 31, 2025 | 961.91 Mn |
| Sep 30, 2025 | 832.76 Mn |
| Jun 30, 2025 | 146.09 Mn |
| Mar 31, 2025 | 160.16 Mn |
| Dec 31, 2024 | 166.48 Mn |
| Sep 30, 2024 | 187.51 Mn |
| Jun 30, 2024 | 185.27 Mn |
| Mar 31, 2024 | 199.03 Mn |
| Dec 31, 2023 | 197.62 Mn |
| Sep 30, 2023 | 202.49 Mn |
| Jun 30, 2023 | 207.43 Mn |
| Mar 31, 2023 | 206.30 Mn |
| Dec 31, 2022 | 209.15 Mn |
| Sep 30, 2022 | 208.06 Mn |
| Jun 30, 2022 | 185.21 Mn |
| Mar 31, 2022 | 201.61 Mn |
| Dec 31, 2021 | 202.11 Mn |
| Sep 30, 2021 | 200.91 Mn |
API Access
BeOne Medicines Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=ONC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "ONC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=ONC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();